DeepMed Research

National Eye Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1968-01-01

Employees: 101

Market Cap: -

Website: http://www.nei.nih.gov

Clinical Trials

Cell Collection to Study Eye Diseases

Recruiting

Conditions: Retinitis Pigmentosa
Retinal Degeneration
Retinal Disease
AMD

First Posted Date: 2011-09-13

Last Posted Date: 2025-05-20

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 930

Registration Number: NCT01432847

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Topical Interferon Gamma for Macular Edema Secondary to Uveitis

Phase 1

Completed

Conditions: Anterior Uveitis
Uveitis

Interventions: Drug: Interferon Gamma-1b

First Posted Date: 2011-06-20

Last Posted Date: 2012-10-08

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 5

Registration Number: NCT01376362

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

The Natural History of Graft-Versus-Host Disease in the Eyes

Completed

Conditions: Graft-Versus-Host Disease

First Posted Date: 2011-06-09

Last Posted Date: 2019-12-03

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 61

Registration Number: NCT01369914

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Study of Dark Adaptation in Age-Related Macular Degeneration

Active, not recruiting

Conditions: Age-Related Macular Degeneration

First Posted Date: 2011-05-12

Last Posted Date: 2025-04-20

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 217

Registration Number: NCT01352975

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate

Phase 1

Terminated

Conditions: Non-infectious Intermediate and Posterior Uveitis

Interventions: Drug: Methotrexate

First Posted Date: 2011-03-14

Last Posted Date: 2019-03-27

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 2

Registration Number: NCT01314417

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Palomid 529 in Patients With Neovascular Age-Related Macular Degeneration

Phase 1

Completed

Conditions: Age-Related Macular Degeneration

First Posted Date: 2011-01-06

Last Posted Date: 2018-07-05

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 5

Registration Number: NCT01271270

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy

Phase 1

Completed

Conditions: Retinal Disease

Interventions: Drug: Finasteride

First Posted Date: 2010-10-25

Last Posted Date: 2024-01-30

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 3

Registration Number: NCT01227993

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Optiquel® as Corticosteroid-sparing Therapy for Chronic Noninfectious Uveitis

Phase 1

Completed

Conditions: Uveitis

Interventions: Drug: B27PD
Drug: Placebo

First Posted Date: 2010-09-06

Last Posted Date: 2018-09-11

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 31

Registration Number: NCT01195948

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema

Terminated

Conditions: Diabetic Retinopathy
Diabetic Macular Edema

First Posted Date: 2010-07-23

Last Posted Date: 2017-10-06

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 68

Registration Number: NCT01168258

Locations: 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

Genotype-Phenotype Study of Patients With Plaquenil -Induced Retinal Toxicity, With Evaluation of the ABCA4 Gene

Recruiting

Conditions: Retinal Disease
Genotype

First Posted Date: 2010-06-16

Last Posted Date: 2025-05-20

Lead Sponsor: National Eye Institute (NEI)

Target Recruit Count: 300

Registration Number: NCT01145196

Locations: 🇺🇸
National Institutes of Health Clinical Center, Bethesda, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy